CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gritz, E. R.
Right arrow Articles by Chonkich, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gritz, E. R.
Right arrow Articles by Chonkich, G.

Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 3 261-270, Copyright © 1993 by American Association for Cancer Research


ARTICLES

Predictors of long-term smoking cessation in head and neck cancer patients

ER Gritz, CR Carr, D Rapkin, E Abemayor, LJ Chang, WK Wong, TR Belin, T Calcaterra, KT Robbins and G Chonkich
Division of Cancer Control, Jonsson Comprehensive Cancer Center, UCLA School of Medicine.

Cigarette smoking is a major risk factor for head and neck cancer, and individuals who continue to smoke past diagnosis and treatment are at elevated risk for further disease. In a randomized controlled trial, a state of the art provider-delivered smoking cessation intervention was compared to a usual care advice control condition. The intervention consisted of surgeon- or dentist-delivered advice to stop smoking, a contracted quit date, tailored written materials, and booster advice sessions. Subjects were 186 patients with newly diagnosed first primary squamous cell carcinomas of the upper aerodigestive tract who had smoked cigarettes within the past year. At randomization, 88.2% of subjects were current smokers. At 12-month follow-up, 70.2% of subjects completing the trial (n = 114) were continuous abstainers; among baseline smokers alone the continuous abstinence (CA) rate was 64.6%. The cotinine validation rate at 12 months was 89.6%. Modeling techniques were utilized in order to derive expected CA rates, which included noncompleter subjects (n = 72). The CA rate expected at 1 year for the entire patient population was 64.2%, and for smokers alone the expected CA rate was 59.4%. Logistic regression analysis carried out on baseline smokers identified predictors of 12-month CA status. These included medical treatment, stage of change, age, nicotine dependence, and race. The intervention effect was not significant, although the sign of the effect was positive. Based on these findings, we recommend systematic brief advice to stop smoking for head and neck cancer patients, with a stepped care approach for patients less able to quit.


This article has been cited by other articles:


Home page
Am. J. Public HealthHome page
E. M. Augustson, K. L. Wanke, S. Rogers, A. W. Bergen, N. Chatterjee, K. Synder, D. Albanes, P. R. Taylor, and N. E. Caporaso
Predictors of Sustained Smoking Cessation: A Prospective Analysis of Chronic Smokers From the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study
Am J Public Health, March 1, 2008; 98(3): 549 - 555.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. R. Gritz, L. Sarna, C. Dresler, and C. G. Healton
Building a United Front: Aligning the Agendas for Tobacco Control, Lung Cancer Research, and Policy
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 859 - 863.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
S. A. Duffy, D. L. Ronis, M. Valenstein, K. E. Fowler, M. T. Lambert, C. Bishop, J. E. Terrell, and the University of Michigan Head and Neck Cancer Te
Depressive Symptoms, Smoking, Drinking, and Quality of Life Among Head and Neck Cancer Patients
Psychosomatics, April 1, 2007; 48(2): 142 - 148.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. B. Stull, D. C. Snyder, and W. Demark-Wahnefried
Lifestyle Interventions in Cancer Survivors: Designing Programs That Meet the Needs of This Vulnerable and Growing Population
J. Nutr., January 1, 2007; 137(1): 243S - 248S.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. Demark-Wahnefried, B. M. Pinto, and E. R. Gritz
Promoting Health and Physical Function Among Cancer Survivors: Potential for Prevention and Questions That Remain
J. Clin. Oncol., November 10, 2006; 24(32): 5125 - 5131.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. A. Duffy, D. L. Ronis, M. Valenstein, M. T. Lambert, K. E. Fowler, L. Gregory, C. Bishop, L. L. Myers, F. C. Blow, and J. E. Terrell
A Tailored Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer Patients.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2203 - 2208.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. Cartmel, D. Bowen, D. Ross, E. Johnson, and S. T. Mayne
A Randomized Trial of an Intervention to Increase Fruit and Vegetable Intake in Curatively Treated Patients with Early-Stage Head and Neck Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2848 - 2854.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. R. Gritz, C. Dresler, and L. Sarna
Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2287 - 2293.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. Demark-Wahnefried, N. M. Aziz, J. H. Rowland, and B. M. Pinto
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
J. Clin. Oncol., August 20, 2005; 23(24): 5814 - 5830.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Sudbo, R. Samuelsson, B. Risberg, S. Heistein, C. Nyhus, M. Samuelsson, R. Puntervold, E. Sigstad, B. Davidson, A. Reith, et al.
Risk Markers of Oral Cancer in Clinically Normal Mucosa As an Aid in Smoking Cessation Counseling
J. Clin. Oncol., March 20, 2005; 23(9): 1927 - 1933.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Lerman, F. Patterson, and W. Berrettini
Treating Tobacco Dependence: State of the Science and New Directions
J. Clin. Oncol., January 10, 2005; 23(2): 311 - 323.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Gorin and J. E. Heck
Meta-Analysis of the Efficacy of Tobacco Counseling by Health Care Providers
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2012 - 2022.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. L. Andersen, W. B. Farrar, D. M. Golden-Kreutz, R. Glaser, C. F. Emery, T. R. Crespin, C. L. Shapiro, and W. E. Carson III
Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial
J. Clin. Oncol., September 1, 2004; 22(17): 3570 - 3580.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Y. I. Garces and J. T. Hays
Tobacco Dependence: Why Should an Oncologist Care?
J. Clin. Oncol., May 1, 2003; 21(9): 1884 - 1886.
[Full Text] [PDF]


Home page
Health Educ ResHome page
C. M. McBride, K. M. Emmons, and I. M. Lipkus
Understanding the potential of teachable moments: the case of smoking cessation
Health Educ. Res., April 1, 2003; 18(2): 156 - 170.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. A. Schnoll, B. Zhang, M. Rue, J. E. Krook, W. T. Spears, A. C. Marcus, and P. F. Engstrom
Brief Physician-Initiated Quit-Smoking Strategies for Clinical Oncology Settings: A Trial Coordinated by the Eastern Cooperative Oncology Group
J. Clin. Oncol., January 15, 2003; 21(2): 355 - 365.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. S. Cox, C. A. Patten, J. O. Ebbert, A. A. Drews, G. A. Croghan, M. M. Clark, T. D. Wolter, P. A. Decker, and R. D. Hurt
Tobacco Use Outcomes Among Patients With Lung Cancer Treated for Nicotine Dependence
J. Clin. Oncol., August 15, 2002; 20(16): 3461 - 3469.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. H. Brandon
Behavioral Tobacco Cessation Treatments: Yesterday's News or Tomorrow's Headlines?
J. Clin. Oncol., September 15, 2001; 19(90001): 64s - 68.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Munafo, N Rigotti, T Lancaster, L Stead, and M Murphy
Interventions for smoking cessation in hospitalised patients: a systematic review
Thorax, August 1, 2001; 56(8): 656 - 663.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
E. R Gritz
Facilitating smoking cessation in cancer patients
Tob. Control, March 1, 2000; 9(90001): i50 - 50.
[Full Text] [PDF]


Home page
JCOHome page
E. R. Gritz, C. L. Carmack, C. de Moor, A. Coscarelli, C. W. Schacherer, E. G. Meyers, and E. Abemayor
First Year After Head and Neck Cancer: Quality of Life
J. Clin. Oncol., January 1, 1999; 17(1): 352 - 352.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1993 by the American Association for Cancer Research.